The Drugs of Abuse Array V (DoA V) will enable detection of eight designer drugs and their metabolites within a single undivided specimen.
The panel targets Methcathinone, Mephedrone, MDPV (also known as bath salts), Benzylpiperazines, Phenylpiperazines, Mescaline, Salvinorin and other Synthetic Cannabinoids.
Randox launched an ELISA for the detection of synthetic cannabinoids in October 2011, which offers effective screening for designer drugs.